Cite Filings / DYN / 0001193125-26-084178

Feed Companies Filings Check

Sign in

10-K

Annual Report

Dyne Therapeutics, Inc. Filed 2026-03-02 Acc 0001193125-26-084178

Documents 1

10-K Annual Report , dyn-20251231.htm

Around this filing

2026-03-06 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-03-06 4 CEO & President sold 2,732 shares at $14.90 ($40,707)
2026-03-05 144 Sale of Securities
2026-03-02 S-8 Securities Offered to Employees in Benefit Plans
2026-03-02 8-K Results of operations
2026-03-02 10-K Annual Report
2025-02-27 10-K Annual Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading dyn-20251231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…